1.50

0.00% 0.01

Opko Health Inc (OPK)

Overview News Price History Option Chain Financials Why OPK Down? Discussions Forecast

Opko Health Inc stock is traded at $1.50, with a volume of 967.58K. It is up +0.00% in the last 24 hours and up +7.86% over the past month. OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

Previous Close:

$1.51

Open:

$1.53

24h Volume:

967.58K

Relative Volume:

0.41

Market Cap:

$1.19B

Revenue:

$711.41M

Net Income/Loss:

$-133.73M

P/E Ratio:

-7.8947

EPS:

-0.19

Net Cash Flow:

$-199.99M

1W Performance:

-4.43%

1M Performance:

+7.86%

6M Performance:

+6.71%

1Y Performance:

+3.42%

1-Day Range:

$1.49

$1.5387

1-Week Range:

$1.49

$1.595

52-Week Range:

$1.11

$2.035

Opko Health Inc Stock (OPK) Company Profile

Name

Opko Health Inc

Sector

Healthcare (1146)

Industry

Diagnostics & Research (53)

Phone

305-575-4181

Address

4400 BISCAYNE BLVD., MIAMI, FL

Employee

2,997

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

OPK's Discussions on Twitter

Compare OPK with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
OPK Opko Health Inc	1.5005	1.20B	711.41M	-133.73M	-199.99M	-0.19
TMO Thermo Fisher Scientific Inc	527.36	198.17B	43.21B	6.58B	6.17B	17.28
DHR Danaher Corp	206.12	144.97B	24.01B	3.41B	4.86B	4.7082
IDXX Idexx Laboratories Inc	633.42	49.29B	4.04B	985.66M	774.34M	12.01
A Agilent Technologies Inc	139.22	38.73B	6.79B	1.22B	1.09B	4.2644
IQV Iqvia Holdings Inc	204.51	33.69B	15.70B	1.24B	2.01B	6.9036

Opko Health Inc Stock (OPK) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-25-25	Initiated	JP Morgan	Neutral
Jun-29-23	Upgrade	Barrington Research	Mkt Perform → Outperform
Dec-15-22	Initiated	H.C. Wainwright	Buy
Jan-24-22	Downgrade	Barrington Research	Outperform → Mkt Perform
Jun-21-21	Initiated	Ladenburg Thalmann	Buy
Nov-25-19	Initiated	Piper Jaffray	Overweight
Mar-02-18	Downgrade	JP Morgan	Neutral → Underweight
Sep-14-17	Downgrade	JP Morgan	Overweight → Neutral
Jun-21-16	Reiterated	Standpoint Research	Buy
Jun-03-16	Initiated	Standpoint Research	Buy
Mar-31-16	Reiterated	Barrington Research	Outperform
Oct-16-15	Initiated	JP Morgan	Overweight
Sep-11-15	Downgrade	Jefferies	Buy → Hold
Mar-03-15	Downgrade	Oppenheimer	Outperform → Perform
May-12-14	Reiterated	Oppenheimer	Outperform
Mar-14-14	Initiated	Oppenheimer	Outperform
Nov-13-13	Reiterated	Ladenburg Thalmann	Buy
May-30-13	Reiterated	Ladenburg Thalmann	Buy
Oct-22-12	Initiated	Barrington Research	Outperform
Dec-01-11	Reiterated	Ladenburg Thalmann	Buy
Jul-14-11	Initiated	Ladenburg Thalmann	Buy

View All

Opko Health Inc Stock (OPK) Latest News

08:14 AM

When is the best time to exit OPKO Health Inc.Dollar Strength & AI Based Buy and Sell Signals - newser.com

08:14 AM

Oct 12, 2025

Analyzing OPKO Health Inc. with multi timeframe chartsMarket Growth Summary & Expert Curated Trade Ideas - newser.com

Oct 12, 2025

Oct 10, 2025

OPKO Health Experiences Evaluation Revision Amid Mixed Market Signals and Performance Trends - Markets Mojo

Oct 10, 2025

OPKO Health (NASDAQ:OPK) Receives Sell (D-) Rating from Weiss Ratings - MarketBeat

Oct 10, 2025

Clinical Laboratory Tests Market See Incredible Growth 2025-2032 | ARUP Laboratories, OPKO Health, Inc., UNILABS - industrytoday.co.uk

Oct 10, 2025

Oct 09, 2025

Smart tools for monitoring OPKO Health Inc.’s price actionJuly 2025 PostEarnings & Safe Entry Zone Tips - newser.com

Oct 09, 2025

Real time pattern detection on OPKO Health Inc. stock2025 Technical Overview & Low Drawdown Trading Strategies - newser.com

Oct 09, 2025

Oct 08, 2025

NextPlat Issues CEO Shareholder Update Letter - Benzinga

Oct 08, 2025

Oct 06, 2025

OPKO acquiring company from Barcelona - Law.com

Oct 06, 2025

Can machine learning forecast OPKO Health Inc. recoveryPortfolio Return Summary & Safe Entry Zone Identification - newser.com

Oct 06, 2025

How OPKO Health Inc. stock performs in weak economyJuly 2025 Big Picture & Smart Investment Allocation Tips - newser.com

Oct 06, 2025

Why OPKO Health Inc. stock attracts global investorsMarket Volume Summary & Reliable Momentum Entry Alerts - newser.com

Oct 06, 2025

Technical signs of recovery in OPKO Health Inc.July 2025 Highlights & Fast Moving Market Watchlists - newser.com

Oct 06, 2025

How OPKO Health Inc. (XCY) stock reacts to stronger dollarJuly 2025 Catalysts & Weekly Chart Analysis and Guides - newser.com

Oct 06, 2025

Oct 05, 2025

How to manage a losing position in OPKO Health Inc.Weekly Trend Recap & Expert Curated Trade Setup Alerts - newser.com

Oct 05, 2025

Ranking OPKO Health Inc. among high performing stocks via toolsQuarterly Earnings Summary & Entry Point Confirmation Alerts - newser.com

Oct 05, 2025

What institutional flow reveals about OPKO Health Inc.Portfolio Update Report & Breakout Confirmation Trade Signals - newser.com

Oct 05, 2025

OPKO Health (OPK): Valuation Insights as Clinical Pipeline Progress and Asset Sales Draw Investor Focus - Sahm

Oct 05, 2025

Oct 04, 2025

Washington Growth Strategies LLC Has $1.79 Million Position in OPKO Health, Inc. $OPK - MarketBeat

Oct 04, 2025

Oct 03, 2025

OPKO Health (OPK) Is Up 7.7% After Advancing Immuno-Oncology Pipeline and CEO Boosts Stake Has the Bull Case Changed? - Sahm

Oct 03, 2025

Why OPKO Health (OPK) Is Up 7.7% After Advancing Immuno-Oncology Pipeline and Notable Insider Buying - Sahm

Oct 03, 2025

Opko Health (OPK) Reports Fiscal Q2 2025 Results - MSN

Oct 03, 2025

What machine learning models say about OPKO Health Inc.July 2025 Intraday Action & AI Forecasted Entry/Exit Points - newser.com

Oct 03, 2025

Oct 01, 2025